Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yeye Zhou, Zixuan Zhao, Jihui Li, Bin Zhang, Shibiao Sang, Yiwei Wu & Shengming Deng. (2019)
Prognostic values of baseline, interim and end-of therapy 18F-FDG PET/CT in patients with follicular lymphoma. Cancer Management and Research 11, pages 6871-6885.
Read now
Read now
Articles from other publishers (10)
A. Díaz-Silván, L.F. Otón-Sánchez, A.P. Caresia-Aróztegui, M. del Puig Cózar-Santiago, J. Orcajo-Rincón, M. de Arcocha-Torres, R.C. Delgado-Bolton & D. Cabello-García. (2022) Clinical application of [18F]FDG PET/CT in follicular lymphoma. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 41:3, pages 202-212.
Crossref
Crossref
A. Díaz-Silván, L.F. Otón-Sánchez, A.P. Caresia-Aróztegui, M. del Puig Cózar-Santiago, J. Orcajo-Rincón, M. de Arcocha-Torres, R.C. Delgado-Bolton & D. Cabello-García. (2022) Aplicación clínica de la [18F]FDG PET/TC en el linfoma folicular. Revista Española de Medicina Nuclear e Imagen Molecular 41:3, pages 202-212.
Crossref
Crossref
Gaetano Paone, Mariana Raditchkova-Sarnelli, Teresa Ruberto-Macchi, Marco Cuzzocrea, Emanuele Zucca, Luca Ceriani & Luca Giovanella. (2021) Limited benefit of additional contrast-enhanced CT to end-of-treatment PET/CT evaluation in patients with follicular lymphoma. Scientific Reports 11:1.
Crossref
Crossref
J.G. Peacock, C.T. Christensen & K.P. Banks. (2019) RESISTing the Need to Quantify: Putting Qualitative FDG-PET/CT Tumor Response Assessment Criteria into Daily Practice. American Journal of Neuroradiology.
Crossref
Crossref
Norifumi Tsukamoto, Akihiko Yokohama, Tetsuya Higuchi, Takeki Mitsui, Hiromi Koiso, Makiko Takizawa, Hiroaki Shimizu, Takuma Ishizaki, Morio Matsumoto, Kohtaro Toyama, Tohru Sakura, Hidemi Ogura, Takayuki Saitoh, Fumihiro Ishida, Hirokazu Murakami, Yoshito Tsushima & Hiroshi Handa. (2018) Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy. International Journal of Hematology 109:1, pages 91-97.
Crossref
Crossref
Judith Trotman, Sally F Barrington, David Belada, Michel Meignan, Robert MacEwan, Carolyn Owen, Václav Ptáčník, András Rosta, Günter R Fingerle-Rowson, Jiawen Zhu, Tina Nielsen, Deniz Sahin, Wolfgang Hiddemann, Robert E Marcus, Andrew Davies, Mark Hertzberg, Andrew Grigg, Paul Cannell, Hang Quach, Stephen Opat, Constantine Tam, Paula Marlton, Ann Janssens, Fritz Offner, Koen Van eygen, Randeep Sangha, Pam Mckay, Jonathan Wilson, Richard Van Der Jagt, Daryl Roitman, Marek Trneny, Jiri Mayer, Katell Le Du, Philippe Solal-Celigny, Guillaume Cartron, Charles Foussard, Norbert Frickhofen, Peter Schmidt, Ullrich Graeven, Tobias Gaska, Rudolf Schlag, Martin Sökler, Gabriele Prange-Krex, Axel Florschütz, Hans-Walter Lindemann, Christoph Schimmelpfennig, Solveig Tonndorf, Mathias Hänel, Georg Hess, Enrico Schalk, Heiko Hütten, Gottfried Doelken, Michael Pfreundschuh, Ulrich Keller, Michael Herold, Roswitha Forstpointner, Ursula Vehling-Kaiser, Martin Hoffmann, Zita Borbenyi, Miklos Udvardy, Judit Demeter, Alessandro Rambaldi, Enrica Morra, Federico Massimo, Ignazio Majolino, Monica Balzarotti, Gianpietro Semenzato, Miguel Angel Canales Albendea, Francisco Javier Peñalver Parraga, Alfonso Soler Campos, Juan Manuel Sancho Cia, Jose Antonio Marquez Navarro, Carlos Grande Garcia, Herman Nilsson-Ehle, Helen Mccarthy, Chris Pocock, Shalal Sadullah, Ram Malladi, John Radford, Ed Kanfer, Anton Kruger, Dominic Culligan, Martin Dyer, Ruth Pettengell, John Seymour, John Gribben, Saad Al-Ismail, Faris Al-Refaie, Norbert Blesing, Christopher Macnamara, Ann O'callaghan, Andrew Haynes, George Follows, Roderick Johnson, David Cunningham, Kristian Bowles, Graham Collins, Eve Gallop-Evans, Stephen Robinson, Chezhian Subash, James Bailey, Viran Holden, Jeffrey Neidhart, Moacyr De Oliveira, Haluk Tezcan, Kevin Kim, Suman Kambhampati, Keith Lanier, John Mcclean, Kensei Tobinai, Kiyohiko Hatake, Michinori Ogura, Toshiki Uchida, Kiyoshi Ando, Tomohiro Kinoshita, Thomas Höhler, Heribert Stauder, Andreas Kirsch, Michael Koenigsmann, Stephan Kremers, Thomas Illmer, Mathias Witzens-Harig, Paul La Roseé, Jan Dürig, Michael Kneba, Manfred Hensel, Stefan Fuxius, Lothar Bergmann, Kai Hübel, Christian Buske, Reinhard Marks, Gerald Wulf, Christian Lerchenmueller, Rudolf Schmits, Mark Reinwald, Eva Lengfelder, Fiona Scott, Takaaki Chou, Masafumi Taniwaki, Isao Yoshida, Kenichi Ishizawa, Naokuni Uike, Nobuhiko Uoshima, Yuri Kamitsuji, Shinsuke Iida, Ken Ohmine, Kisato Nosaka, Kazuhiko Ide, Takayuki Ishikawa, Pierre Desjardins, Nicholas Finn, Jun Zhu, Wei Li, Li Yu, Hanyun Ren, Yuan Kai Shi, Gang Wu, Xiaonan Hong, Qingyuan Zhang, Jifeng Feng, Rong Zhan, Tongyu Lin, Sirpa Leppa, Regis Costello, Adrian Tempescul, Laurence Sanhes, Olivier Tournilhac, Heinz Kirchen, Holger Hebart, Rudolf Weide, Kathleen Jentsch-Ullrich, Irit Avivi, Arnon Nagler, Ronit Gurion, Ofer Shpilberg, Pietro Leoni, Luca Baldini, Olga Samoylova, Alexandr Myasnikov, Tran-Der Tan, Hung Chang, Kyoya Kumagai, Norifumi Tsukamoto, Kunihiro Tsukasaki, Patrick Beatty, Noriko Usui, Koji Izutsu, Tohru Murayama, Tatsuo Ichinohe, Kohmei Kubo, Fumihiro Ishida, J. Thaddeus Beck, Frank Griesinger, Dzhelil Osmanov, Shaker Dakhil, Aline Clavert, Dai Maruyama, Yasuhito Terui, Kazuhito Yamamoto, Ekkehard Eigendorff, Tsutomu Kobayashi, Satoshi Ichikawa, Ilseung Choi, Katsuya Wada, Yoshitaka Kikukawa, Masao Matsuoka, Takayuki Yoshino & Yosuke Minami. (2018) Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial. The Lancet Oncology 19:11, pages 1530-1542.
Crossref
Crossref
Mayur S. Narkhede & Bruce D. Cheson. (2018) Surrogate Endpoints and Risk Adaptive Strategies in Previously Untreated Follicular Lymphoma. Clinical Lymphoma Myeloma and Leukemia 18:7, pages 447-451.
Crossref
Crossref
Salvatore Annunziata, Annarosa Cuccaro, Maria Chiara Tisi, Stefan Hohaus & Vittoria Rufini. (2018) FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET). Annals of Nuclear Medicine 32:5, pages 372-377.
Crossref
Crossref
Marc Sorigue & Juan-Manuel Sancho. (2017) Current prognostic and predictive factors in follicular lymphoma. Annals of Hematology 97:2, pages 209-227.
Crossref
Crossref
Hugo J. A. Adams & Thomas C. Kwee. (2016) No convincing evidence to support postinduction FDG-PET in follicular lymphoma. Annals of Hematology 95:12, pages 2085-2086.
Crossref
Crossref